ETFs
B
BIIB
Biogen Inc
203.41
+1.22+0.60%Opening10:59 07/27 EDT
OPEN/PREV CLOSE202.75/202.19
TODAY RANGE201.91-204.47
VOL129.13K
MARKET CAP30.03B
52 WEEK RANGE121.05-219.72
AVG VOL (3M)1.25M
% TURNOVER0.09%
TURNOVER--
P/E (TTM)21.83
% RANGE1.27%
EPS(TTM)9.32
P/E(FORWARD)24.85
P/B1.610
BVPS126.37
DIVIDEND--
P/S3.017
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP29.95B
SHARES OUTSTANDING147.64M
NEXT EARNINGS07/29-08/03
FREE FLOAT147.26M
LOT SIZE1
EX-DATE02/02/2017
News
Press Releases
Financial Reports
Profile
Simply Wall St·4d ago
At-Home LEQEMBI Autoinjector And New Tau Data Might Change The Case For Investing In Biogen (BIIB)
Seeking Alpha·5d ago
Key FDA drugs advisory committee to be reconstituted
Seeking Alpha·5d ago
Biogen And The Limitation Of The Tau Approach To Alzheimer's Disease
Dow Jones·6d ago
Biogen Is Maintained at Buy by Guggenheim
Dow Jones·6d ago
Biogen Is Maintained at Neutral by B of A Securities
TipRanks·6d ago
Biogen price target raised to $280 from $260 at Guggenheim
TipRanks·6d ago
Biogen price target lowered to $215 from $217 at BofA
Same Industry
Name/Symbol
Change%
Price